Due to concerns with the risk of thrombosis with thrombocytopenia syndrome (TTS), the FDA is limiting the authorized use of the Johnson & Johnson (J&J) COVID-19 "vaccine" to individuals 18 years of age and older for whom other authorized "vaccines" are not accessible.
